(Reuters) - Johnson & Johnson reported a 1.7 percent rise in fourth-quarter sales, due to a strong demand for its newer products.
The diversified healthcare company's sales rose to $18.11 billion in the fourth quarter from $17.81 billion a year earlier.
Net earnings rose to $3.81 billion, or $1.38 per share, from $3.22 billion, or $1.15 per share.
The band-aid maker also said on Tuesday that it was looking to divest its diabetes care division.
(Reporting by Natalie Grover in Bengaluru; Editing by Savio D'Souza)